UltraVision CEO announces FDA approval during Queen’s Awards Presentation
The Queen’s Awards for Enterprise, the most prestigious award for a UK business, was bestowed upon UltraVision in April this year, specifically for KeraSoft; a patented soft contact lens for Irregular Corneas and Keratoconus.
The official presentation by Her Majesty’s representative, Lord Lieutenant of Bedfordshire, Sir Samuel Whitbread KCVO JP, took place at UltraVision’s Head Office in Leighton Buzzard. All UltraVision staff members attended, along with guests from the optical profession and community leaders. Sir Samuel Whitbread presented the Company with an official scroll, signed by Her Majesty The Queen and Gordon Brown, the Prime Minister at the time the award was given.
This is the second Queen’s Award UltraVision has received; its first was given in 2006 for UltraWave and SAM technologies.
“To receive the Queen’s Award once is a serious achievement, but twice is out of this world” said Lomas. “We were improving people’s vision but now our team is taking our technologies to new levels and dramatically changing lives for the better”.
J Keith Lomas, UltraVision’s CEO, gave a presentation prior to Sir Samuel Whitbread’s presentation, where he talked about the history of contact lenses; from the first concept by Leonardo da Vinci over 500 years ago to contact lenses as we know them today.
Mr Lomas also announced that, in partnership with Contamac and others, KeraSoft® lenses have recently received FDA approval, which is another immense achievement for UltraVision and its staff. FDA approval means that these soft lenses for Irregular Corneas and Keratoconus can now be supplied in the USA, the largest contact lens market in the world.
Keith commented, “To have KeraSoft FDA approved is yet another accomplishment for the team and will allow many more patients access to this life-changing lens”.
Patients can have irregular corneas for a number of reasons including disease, trauma and corneal transplants. Standard contact lenses or spectacles do not successfully address such complexities so patients can have considerably reduced vision.
In picture are: (L-R) John Shilling, Deputy Master, The Worshipful Company of Spectacle Makers; Sir Samuel Whitbread; J Keith Lomas, CEO, UltraVision; Mr Gordon Perham, Town Mayor, Leighton-Linslade.